Patents by Inventor Julian Lieb

Julian Lieb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5145686
    Abstract: Topical pharmaceutical compositions for the treatment of lesions of the skin or mucous membranes containing a physiologically acceptable lithium salt together with at least one substance selected from substances capable of selectively increasing the in vivo level of E-series prostaglandins, substances capable of inhibiting cyclooxygenase enzyme, substances capable of inhibiting the formation of lipoxygenase products, and lysine.
    Type: Grant
    Filed: January 8, 1992
    Date of Patent: September 8, 1992
    Assignee: Efamol Limited
    Inventors: David F. Horrobin, Julian Lieb
  • Patent number: 4490385
    Abstract: A method for the treatment of inflammatory disorders and disorders of immunity, which disorders are characterized by excessive prostaglandin E2 biosynthesis, which method comprises administering an effective amount of a monoamine oxidase inhibitor.
    Type: Grant
    Filed: October 5, 1983
    Date of Patent: December 25, 1984
    Inventor: Julian Lieb
  • Patent number: 4409243
    Abstract: A method for the treatment of inflammatory disorders and disorders of immunity, which disorders are characterized by excessive prostaglandin E2 biosynthesis, which method comprises administering an effective amount of a monoamine oxidase inhibitor.
    Type: Grant
    Filed: November 9, 1981
    Date of Patent: October 11, 1983
    Inventor: Julian Lieb
  • Patent number: 4386072
    Abstract: A method for the treatment or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm, by administering dihomo-.gamma.-linolenic acid or a bioprecursor thereof conjointly with a physiologically acceptable lithium salt. Vitamin E and related tocopherols may optionally be also administered.
    Type: Grant
    Filed: February 3, 1982
    Date of Patent: May 31, 1983
    Inventors: David F. Horrobin, Julian Lieb
  • Patent number: 4328243
    Abstract: A method for the treatment and/or prophylaxis of the side-effects of lithium treatment in a subject suffering from manic-depressive psychosis, which method comprises administering to the subject an effective amount therefor of dihomogamma-linolenic acid and/or a biosynthetic precursor thereof.
    Type: Grant
    Filed: April 7, 1981
    Date of Patent: May 4, 1982
    Inventors: David F. Horrobin, Julian Lieb